8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 8.01 · Other EventsItem 9.01 · Financial Statements
Danaher names Julie Sawyer Montgomery CEO effective October 1
Filed with the SEC on · Summarized by InvestorsBot
Danaher appointed Julie Sawyer Montgomery as president, CEO and a board member effective October 1, 2026, when current CEO Rainer Blair will retire and remain as a senior advisor through March 31, 2027. Montgomery has led the Diagnostics platform since 2020, helping grow revenue from approximately $6.0 billion in 2017 to approximately $11.0 billion today and nearly triple operating profit; Danaher said its previously issued third-quarter and full-year 2026 guidance is unchanged.